ArticleInternational medical case reports journal2026
Suspected Cefuroxime-Induced Cystoid Macular Edema Following Non-Toric Implantable Collamer Lens Implantation: A Case Report.
Article in International medical case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: We present a rare case of suspected cefuroxime-induced cystoid macular edema (CME) subsequent to non-toric implantable collamer lens (ICL) surgery. Case Presentation: A 23-year-old lady with high myopia underwent refractive ICL implantation in both eyes. On the first day, the right eye was performed ICL implantation first, and postoperative uncorrected distance visual acuity (UDVA) was improved to 20/20. On the following day, the left eye underwent ICL implantation. Surprisingly, postoperative UDVA dropped to 20/63 with no improvement upon correction. At the end of each surgery, 0.1 mL of cefuroxime (1.5 mg/0.1 mL) will be injected into the anterior chamber. Scanning laser ophthalmoscopy (SLO) revealed macular edema in the left eye, followed by optical coherence tomography (OCT) confirming CME and serous retinal detachment. With the treatment of pranoprofen and prednisone, the CME decreased significantly and UDVA was increasing on the fifth postoperative day. At six-month follow up, the CME had completely subsided and UDVA reached to 20/20. Conclusion: Acute CME after ICL implantation, anatomically and temporally aligned with intracameral cefuroxime injection and lacking other inflammatory or vascular triggers, strongly points to intracameral cefuroxime ocular toxic syndrome (ICOTS). Ophthalmologists should be aware that suboptimal visual recovery after ICL surgery may indicate CME and must attend to the dose safety of intracameral cefuroxime.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.